AC Immune (ACIU) Non Operating Income (2018)

AC Immune (ACIU) has reported Non Operating Income for 12 consecutive years, with -$16601.1 the latest figure, recorded in Q1 2026.

• In Q1 2026, Non Operating Income fell 104.38% year-over-year to -$16601.1; the TTM figure through Mar 2026 stood at -$1.8 million (down 319.27% YoY), while the FY2025 annual figure was -$1.4 million, down 181.43% from the prior year.
• Non Operating Income fell to -$16601.1 in Q1 2026 per ACIU's latest filing, from $26274.6 in the prior quarter.
• Across five years, Non Operating Income topped out at $3.2 million in Q4 2024 and bottomed at -$2.2 million in Q2 2025.
• Historically, Non Operating Income has averaged -$14604.4 across 5 years, with a median of $26274.6 in 2025.
• Annual changes were most pronounced in 2023 — Non Operating Income plunged 2510.89% — and 2024, when it surged 3732.21%.
• AC Immune's Non Operating Income stood at -$51901.1 in 2022, then slumped by 2510.89% to -$1.4 million in 2023, then surged by 337.89% to $3.2 million in 2024, then tumbled by 99.18% to $26274.6 in 2025, then sank by 163.18% to -$16601.1 in 2026.
• Business Quant data shows ACIU's Non Operating Income at -$16601.1 in Q1 2026, $26274.6 in Q4 2025, and $385033.7 in Q3 2025.